Glioblastoma multiforme: A bigger challenge in resource-limited countries

Division of Pediatric Hematology‑Oncology, Department of Pediatric Subspecialties, KK Women’s and Children’s Hospital, 100 Bukit Timah Road, Singapore

Address for correspondence: Dr. LeLe Aung Division of Pediatric Hematology-Oncology, Department of Pediatric Subspecialties, KK Women’s and Children’s Hospital, 100 Bukit Timah Road Singapore aung.lele@kkh.com.sg

Journal of Neurosciences in Rural Practice

Licence

This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Private Ltd. and was migrated to Scientific Scholar after the change of Publisher; therefore Scientific Scholar has no control over the quality or content of this article.

Conflict of Interest

None declared

References

Fine H. A., Dear K. B., Loeffler J. S., Black P. M., Canellos G. P., . Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer. 1993;71:2585-97.
[Google Scholar]
Stupp R, Dietrich P. Y., Kraljevic S. O., Pica A, Maillard I, Maeder P, et al . Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol. 2002;20:1375-82.
[Google Scholar]
Hegi M. E., Diserens A. C., Gorlia T, Hamou M. F., de Tribolet N, Weller M, et al . MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997-1003.
[Google Scholar]
Krex D, Klink B, Hartmann C, et al . Long-term survival with glioblastoma multiforme. Brain. 2007;130:2596-606.
[Google Scholar]
Kumar N, Kumar P, Angurana S. L., et al . Evalutaion of outcome and prognostic factors in patients with glioblastoma multiforme: A single institution expereicne. J Neurosci Rural Pract. 2013;4:s46-55. suppl 1
[Google Scholar]
Malmström A, Grønberg B. H., Marosi C, Stupp R, Frappaz D, Schultz H, et al . Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomized, phase 3 trial. Lancet Oncol. 2012;13:916-26.
[Google Scholar]
Lo S. S., Chang E. L., . Hypofractionated radiation therapy for glioblastoma: Educational ook manuscript. Am Soc Clin Oncol
[Google Scholar]

Fulltext Views
16

PDF downloads
0

View/Download PDF
Download Citations

BibTeX
RIS

Show Sections

Glioblastoma multiforme: A bigger challenge in resource-limited countries

Conflict of Interest

References

Suggested read for related articles: